VNDA (STOCKS)
Vanda Pharmaceuticals Inc.
$7.220000
+0.000000 (+0.00%)
Prev close: $7.220000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mihael Hristos Polymeropoulos
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $422.62M
- Employees
- 368
- P/E (TTM)
- -1.92
- P/B (TTM)
- 1.30
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.46 | $-1.35 | +0.8915 | +65.96% |
|
Sep 2025 (Q3)
|
$-0.38 | $-0.46 | +0.0824 | +17.82% |
|
Jun 2025 (Q2)
|
$-0.46 | $-0.36 | -0.0962 | -26.44% |
|
Mar 2025 (Q1)
|
$-0.50 | $-0.61 | +0.1086 | +17.84% |
Financial Statements
| Revenues | $216.11M |
| Benefits Costs and Expenses | $354.75M |
| Costs And Expenses | $367.27M |
| Operating Expenses | $367.27M |
| Selling, General, and Administrative Expenses | $237.95M |
| Research and Development | $109.27M |
| Other Operating Expenses | $20.05M |
| Operating Income/Loss | -$151.17M |
| Income/Loss From Continuing Operations After Tax | -$220.47M |
| Income/Loss From Continuing Operations Before Tax | -$138.65M |
| Income Tax Expense/Benefit | $81.83M |
| Income Tax Expense/Benefit, Deferred | $81.44M |
| Net Income/Loss | -$220.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$220.47M |
| Net Income/Loss Available To Common Stockholders, Basic | -$220.47M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.74 |
| Diluted Earnings Per Share | -$3.74 |
| Basic Average Shares | 58,930,157 |
| Diluted Average Shares | 58,930,157 |
| Assets | $488.95M |
| Current Assets | $347.26M |
| Inventory | $1.85M |
| Other Current Assets | $345.41M |
| Noncurrent Assets | $141.69M |
| Fixed Assets | $2.25M |
| Other Non-current Assets | $139.44M |
| Liabilities | $161.76M |
| Current Liabilities | $145.16M |
| Wages | $10.32M |
| Other Current Liabilities | $134.84M |
| Noncurrent Liabilities | $16.60M |
| Equity | $327.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $327.19M |
| Liabilities And Equity | $488.95M |
| Net Cash Flow From Operating Activities | -$109.44M |
| Net Cash Flow From Operating Activities, Continuing | -$109.44M |
| Net Cash Flow From Investing Activities | $94.86M |
| Net Cash Flow From Investing Activities, Continuing | $94.86M |
| Net Cash Flow From Financing Activities | -$2.91M |
| Net Cash Flow From Financing Activities, Continuing | -$2.91M |
| Exchange Gains/Losses | $23.00K |
| Net Cash Flow | -$17.47M |
| Net Cash Flow, Continuing | -$17.49M |
| Comprehensive Income/Loss | -$219.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$219.92M |
| Other Comprehensive Income/Loss | $555.00K |
| Other Comprehensive Income/Loss Attributable To Parent | $555.00K |